Dr. Yoshihiro Noda is an Associate Professor and Chief of the Department of Psychiatry at the International University of Health and Welfare, Mita Hospital in Tokyo, Japan. He previously served as Associate Professor in the Department of Neuropsychiatry at Keio University School of Medicine (2017–2025) and completed a five-year clinical research fellowship at the Centre for Addiction and Mental Health (CAMH), University of Toronto.
His skills and expertise span TMS-EEG, Neuroplasticity, Neurophysiology, Neuromodulation, and clinical applications of rTMS/TBS across mood disorders, schizophrenia-spectrum disorders, and neurocognitive conditions.
As of August 2026, Dr. Noda has authored more than 170 peer‑reviewed publications, with 8006 citations, an h-index of 43, and an i10-index of 112. His work has significantly contributed to advancing neuromodulation research, including major international clinical trials such as THREE-D, FOUR-D, and MAINT-R, and he continues to lead national and international TMS registry initiatives.
Dr. Yoshihiro Noda is an Associate Professor and Chief of the Department of Psychiatry at the International University of Health and Welfare, Mita Hospital in Tokyo, Japan. He previously served as Associate Professor in the Department of Neuropsychiatry at Keio University School of Medicine (2017–2025) and completed a five-year clinical research fellowship at the Centre for Addiction and Mental Health (CAMH), University of Toronto.
His skills and expertise span TMS-EEG, Neuroplasticity, Neurophysiology, Neuromodulation, and clinical applications of rTMS/TBS across mood disorders, schizophrenia-spectrum disorders, and neurocognitive conditions.
As of August 2026, Dr. Noda has authored more than 170 peer‑reviewed publications, with 8006 citations, an h-index of 43, and an i10-index of 112. His work has significantly contributed to advancing neuromodulation research, including major international clinical trials such as THREE-D, FOUR-D, and MAINT-R, and he continues to lead national and international TMS registry initiatives.